Display options
Cite
Arora D, Kumar M, Dubey SD, et al. Immunomodulating effects of rasayana drugs in diabetics - a clinical study. Anc Sci Life. 2002;22(2):42-8
Arora, D., Kumar, M., Dubey, S. D., & Sings, U. (2002). Immunomodulating effects of rasayana drugs in diabetics - a clinical study. Ancient science of life, 22(2), 42-8.
Arora, Deepa, et al. "Immunomodulating effects of rasayana drugs in diabetics - a clinical study." Ancient science of life vol. 22,2 (2002): 42-8.
Arora D, Kumar M, Dubey SD, Sings U. Immunomodulating effects of rasayana drugs in diabetics - a clinical study. Anc Sci Life. 2002 Oct;22(2):42-8. PMID: 22557085; PMCID: PMC3330998.
Copy Download .nbib Format: NLM
Share it on

Anc Sci Life. 2002 Oct;22(2):42-8.

Immunomodulating effects of rasayana drugs in diabetics - a clinical study.

Ancient science of life

Deepa Arora, M Kumar, S D Dubey, Uaha Sings

Affiliations

  1. Department of Pharmacology, Universal College of Medical Sciences, Bhairahawa, Nepal.

PMID: 22557085 PMCID: PMC3330998

Abstract

Immune system plays an important role in pathogenesis of diabetes (DM). Besides hypoglycaemics, rasayanas are indicated in the management of DM. In several studies the immunomodulatroy potentials of rasayanas have been proved. A clinical trial of three rasayana drugs, Asparagus recemosus (AR). Bacopa monnieri (BM) and Centella asiatica (CA) was carried out in diabetics. In this study, diabetics were found to have significantly lower levels of serum IgG, increased serum IgA and comparable levels of IgM. All drugs reverted levels of serum IgG levels in diabetics, however, statistical significance was attained only with AR. Further the increased IgA levels were brought back towards normal. These drugs also increased serum protein levels.

Keywords: Asparagus recemosus; Bacopa monnieri; Centella asiatica; Diabetes; immunoglobulins; immunomodulation; rasayana

Publication Types